Hubhopper(https://hubhopper.com) episodic Investigative journalist Ben Westhoff joins Stronger Weekly to discuss his documentary Antagonist and the hidden truth behind addiction treatment in America. This episode explores the overlooked role of naltrexone, an FDA-approved medication used for opioid and alcohol addiction recovery. Learn why it remains underused, how it compares to methadone and buprenorphine, and the financial systems influencing treatment access. Ben shares powerful insights into public health policy, recovery barriers, and the business side of rehab programs. A must-listen conversation for anyone interested in addiction recovery, healthcare reform, mental health, and evidence-based treatment solutions today.

]]> Investigative journalist Ben Westhoff joins Stronger Weekly to discuss his documentary Antagonist and the hidden truth behind addiction treatment in America. This episode explores the overlooked role of naltrexone, an FDA-approved medication used for opioid and alcohol addiction recovery. Learn why it remains underused, how it compares to methadone and buprenorphine, and the financial systems influencing treatment access. Ben shares powerful insights into public health policy, recovery barriers, and the business side of rehab programs. A must-listen conversation for anyone interested in addiction recovery, healthcare reform, mental health, and evidence-based treatment solutions today.

]]> https://files.hubhopper.com/podcast/481857/1400x1400/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist.jpeg en Copyright 2026 strongerweekly strongerweekly strongerweekly strongerweekly strongerweeklypodcast@gmail.com https://hubhopper.com/podcast/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist/481857 https://hubhopper.com/podcast/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist/481857 https://hubhopper.com/podcast/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist/481857 no 1 no https://listen.hubhopper.com/episode/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist/33003654 https://hubhopper.com/episode/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist https://hubhopper.com/podcast/big-pharma-vs-addiction-recovery-ben-westhoff-on-naltrexone-antagonist/481857 Wed, 29 Apr 2026 12:57:51 +0000 Investigative journalist Ben Westhoff joins Stronger Weekly to discuss his documentary Antagonist and the hidden truth behind addiction treatment in America. This episode explores the overlooked role of naltrexone, an FDA-approved medication used for opioid and alcohol addiction recovery. Learn why it remains underused, how it compares to methadone and buprenorphine, and the financial systems influencing treatment access. Ben shares powerful insights into public health policy, recovery barriers, and the business side of rehab programs. A must-listen conversation for anyone interested in addiction recovery, healthcare reform, mental health, and evidence-based treatment solutions today.

]]> Investigative journalist Ben Westhoff joins Stronger Weekly to discuss his documentary Antagonist and the hidden truth behind addiction treatment in America. This episode explores the overlooked role of naltrexone, an FDA-approved medication used for opioid and alcohol addiction recovery. Learn why it remains underused, how it compares to methadone and buprenorphine, and the financial systems influencing treatment access. Ben shares powerful insights into public health policy, recovery barriers, and the business side of rehab programs. A must-listen conversation for anyone interested in addiction recovery, healthcare reform, mental health, and evidence-based treatment solutions today.

]]> 42 strongerweeklypodcast@gmail.com strongerweekly full